zky001
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Feb 28, 2020 (NCT04228926)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06209203 | Phase 2 | Aug 3, 2022 | Fudan University, Zhaoke (Guangzhou) Pharmaceutical Limited |
| NCT06213727 | Phase 2 | Mar 15, 2022 | Zhaoke (Guangzhou) Pharmaceutical Limited |
| NCT07132437 | Phase 1 | Dec 29, 2021 | Capital Medical University, Zhaoke (Guangzhou) Pharmaceutical Limited |
| NCT07120308 | Phase 2 | Sep 15, 2021 | Zhaoke (Guangzhou) Pharmaceutical Limited |
| NCT04228926 | Phase 2 | Feb 28, 2020 | Capital Medical University, Lee's Pharmaceutical |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhaoke (Guangzhou) Pharmaceutical Limited | Government | 4 | 4 | 2 | 2021 |
| Capital Medical University | Academic/Hospital | 2 | 0 | 2 | 2020 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Lee's Pharmaceutical | For profit | 1 | 1 | 1 | 2020 |
4 organizations
Page 1 / 1